Correlation Between Humana and Invesco PureBeta

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Humana and Invesco PureBeta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humana and Invesco PureBeta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humana Inc and Invesco PureBeta MSCI, you can compare the effects of market volatilities on Humana and Invesco PureBeta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humana with a short position of Invesco PureBeta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humana and Invesco PureBeta.

Diversification Opportunities for Humana and Invesco PureBeta

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Humana and Invesco is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Humana Inc and Invesco PureBeta MSCI in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco PureBeta MSCI and Humana is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humana Inc are associated (or correlated) with Invesco PureBeta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco PureBeta MSCI has no effect on the direction of Humana i.e., Humana and Invesco PureBeta go up and down completely randomly.

Pair Corralation between Humana and Invesco PureBeta

Considering the 90-day investment horizon Humana Inc is expected to generate 3.46 times more return on investment than Invesco PureBeta. However, Humana is 3.46 times more volatile than Invesco PureBeta MSCI. It trades about 0.03 of its potential returns per unit of risk. Invesco PureBeta MSCI is currently generating about 0.06 per unit of risk. If you would invest  34,765  in Humana Inc on February 21, 2024 and sell it today you would earn a total of  757.00  from holding Humana Inc or generate 2.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Humana Inc  vs.  Invesco PureBeta MSCI

 Performance 
       Timeline  
Humana Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Humana Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Humana is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Invesco PureBeta MSCI 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco PureBeta MSCI are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Invesco PureBeta may actually be approaching a critical reversion point that can send shares even higher in June 2024.

Humana and Invesco PureBeta Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Humana and Invesco PureBeta

The main advantage of trading using opposite Humana and Invesco PureBeta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humana position performs unexpectedly, Invesco PureBeta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco PureBeta will offset losses from the drop in Invesco PureBeta's long position.
The idea behind Humana Inc and Invesco PureBeta MSCI pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance